# CARPEUS : Effect of Carvedilol on the Portosystemic Gradient as Measured by Endoscopic Ultrasound

> **NCT06861075** · NA · RECRUITING · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 30 (estimated)

## Conditions studied

- Cirrhosis
- Portal Hypertension Related to Cirrhosis

## Interventions

- **DRUG:** Carvedilol

## Key facts

- **NCT ID:** NCT06861075
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-16
- **Primary completion:** 2028-03-01
- **Final completion:** 2028-04-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06861075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06861075, "CARPEUS : Effect of Carvedilol on the Portosystemic Gradient as Measured by Endoscopic Ultrasound". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT06861075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*